Immunomodulatory effects in vitro of vitamin K antagonist acenocoumarol

Thrombosis Research

Volumn 131, Issue 6, 2013, Pages

  Schroecksnadel, S ^a   Gostner, J ^a   Jenny, M ^a   Kurz, K ^b   Schennach, H ^c   Weiss, G ^b   Fuchs, D ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; KYNURENINE; NEOPTERIN; PHYTOHEMAGGLUTININ; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD CLOTTING; CARCINOMA CELL; CARDIOVASCULAR DISEASE; CELL STRAIN CACO 2; CELL VIABILITY; COLON CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IN VITRO STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REPORTER GENE;

ACENOCOUMAROL; ANTICOAGULANTS; CACO-2 CELLS; CELL LINE; CELLS, CULTURED; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MITOGENS; NEOPTERIN; NF-KAPPA B; PHYTOHEMAGGLUTININS; TRYPTOPHAN; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN K;

EID: 84878870522     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.02.012     Document Type: Article

References (42)

1. A. Gómez-Outes, M.L. Suárez-Gea, G. Calvo-Rojas, R. Lecumberri, E. Rocha, and C. Pozo-Hernández Discovery of anticoagulant drugs: a historical perspective Curr Drug Discov Technol 9 2012 83 104
2. E. Previtali, P. Bucciarelli, S.M. Passamonti, and I. Martinelli Risk factors for venous and arterial thrombosis Blood Transfus 9 2011 120 138
3. J.E. McLaren, and D.P. Ramji Interferon gamma: a master regulator of atherosclerosis Cytokine Growth Factor Rev 20 2009 125 135
4. C.F. Nathan Peroxide and pteridine: A hypothesis on the regulation of macrophage antimicrobial activity by interferon-γ I. Gresser, J. Vilcek, Interferon 7 1986 Academic Press London 125 143
5. C. Huber, J.R. Batchelor, D. Fuchs, A. Hausen, A. Lang, and D. Niederwieser Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon gamma J Exp Med 160 1984 310 316
6. C. Murr, B. Widner, B. Wirleitner, and D. Fuchs Neopterin as a marker for immune system activation Curr Drug Metab 3 2002 175 187
7. D. Fuchs, P. Avanzas, R. Arroyo-Espliguero, M. Jenny, L. Consuegra-Sanchez, and J.C. Kaski The role of neopterin in atherogenesis and cardiovascular risk assessment Curr Med Chem 16 2009 4644 4653
8. G.I. Byrne, L.K. Lehmann, J.G. Kirschbaum, E.C. Borden, C.M. Lee, and R.R. Brown Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity J Interferon Res 6 1986 389 396
9. E.R. Werner, G. Bitterlich, D. Fuchs, A. Hausen, G. Reibnegger, and G. Szabo Human macrophages degrade tryptophan upon induction by interferon-gamma Life Sci 41 1987 273 280
10. E.R. Pfefferkorn Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan Proc Natl Acad Sci U S A 81 1984 908 912
11. Y. Ozaki, M.P. Edelstein, and D.S. Duch Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma Proc Natl Acad Sci U S A 85 1988 1242 1246
12. D.H. Munn, E. Shafizadeh, J.T. Attwood, I. Bondarev, A. Pashine, and A.L. Mellor Inhibition of T cell proliferation by macrophage tryptophan catabolism J Exp Med 189 1999 1363 1372
13. P. Hwu, M.X. Du, R. Lapointe, M. Do, M.W. Taylor, and H.A. Young Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation J Immunol 164 2000 3596 3599
14. F. Fallarino, U. Grohmann, C. Vacca, R. Bianchi, C. Orabona, and A. Spreca T cell apoptosis by tryptophan catabolism Cell Death Differ 9 2002 1069 1077
15. D. Fuchs, A.A. Moeller, G. Reibnegger, E. Stoeckle, E.R. Werner, and H. Wachter Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms J Acquir Immune Defic Syndr 3 1990 873 876
16. K. Schroecksnadel, B. Wirleitner, C. Winkler, and D. Fuchs Monitoring tryptophan metabolism in chronic immune activation Clin Chim Acta 364 2006 82 90
17. P. Avanzas, R. Arroyo-Espliguero, J. Cosin-Sales, J. Quiles, E. Zouridakis, and J.C. Kaski Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease Am J Cardiol 93 2004 627 629
18. T.B. Grammer, D. Fuchs, B.O. Böhm, B.R. Winkelmann, and W. Maerz Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography (The Ludwigshafen Risk and Cardiovascular Health Study) Clin Chem 55 2009 115 146
19. E.R. Pedersen, Ø. Midttun, P.M. Ueland, H. Schartum-Hansen, R. Seifert, and J. Igland Systemic markers of interferon-γ-mediated immune activation and long-term prognosis in patients with stable coronary artery disease Arterioscler Thromb Vasc Biol 31 2011 698 704
20. M. Levi, T. van der Poll, and M. Schultz Infection and inflammation as risk factors for thrombosis and atherosclerosis Semin Thromb Hemost 38 2012 506 514
21. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
22. M. Jenny, M. Klieber, D. Zaknun, S. Schroecksnadel, K. Kurz, and M. Ledochowski In vitro testing for anti-inflammatory properties of compounds employing peripheral blood mononuclear cells freshly isolated from healthy donors Inflamm Res 60 2011 127 135
23. S. Schroecksnadel, M. Jenny, K. Kurz, A. Klein, M. Ledochowski, and F. Uberall LPS-induced NF-kappaB expression in THP-1Blue cells correlates with neopterin production and activity of indoleamine 2,3-dioxygenase Biochem Biophys Res Commun 399 2010 642 646
24. B. Widner, E.R. Werner, H. Schennach, H. Wachter, and D. Fuchs Simultaneous measurement of serum tryptophan and kynurenine by HPLC Clin Chem 43 1997 2424 2426
25. C. Murr, L.C. Fuith, B. Widner, B. Wirleitner, G. Baier-Bitterlich, and D. Fuchs Increased neopterin concentrations in patients with cancer: indicator of oxidative stress? Anticancer Res 19 1999 1721 1728
26. R. Schreck, P. Rieber, and P.A. Baeuerle Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1 EMBO J 10 1991 2247 2258
27. K. Asehnoune, D. Strassheim, S. Mitra, J.Y. Kim, and E. Abraham Involvement of reactive oxygen species in toll-like receptor 4-dependent activation of NF-kappaB J Immunol 15 2004 2522 2529
28. E. Naik, and V.M. Dixit Mitochondrial reactive oxygen species drive proinflammatory cytokine production J Exp Med 208 2011 417 420
29. A.C. Terentis, M. Freewan, T.S. Sempértegui Plaza, M.J. Raftery, R. Stocker, and S.R. Thomas The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues Biochemistry 49 2010 591 600
30. V. Kohli, D. Sharma, S.K. Sandur, S. Suryavanshi, and K.B. Sainis Immune responses to novel allergens and modulation of inflammation by vitamin K3 analogue: a ROS dependent mechanism Int Immunopharmacol 11 2011 233 243
31. K. Schroecksnadel, C. Winkler, B. Wirleitner, and H. Schennach Fuchs d. Aspirin downregulates tryptophan degradation in stimulated human peripheral blood mononuclear cells in vitro Clin Exp Immunol 140 2005 41 45
32. X. Li, Z. Zheng, X. Li, and X. Ma Unfractionated heparin inhibits lipopolysaccharide-induced inflammatory response through blocking p38 MAPK and NFκB activation on endothelial cell Cytokine 60 2012 114 121
33. G. Neurauter, B. Wirleitner, A. Laich, H. Schennach, G. Weiss, and D. Fuchs Atorvastatin suppress interferon-γ- induced neopterin formation and tryptophan degradation in human peripheral blood mononuclear cells and in monocytic cell lines Clin Exp Immunol 131 2003 264 267
34. M. Jenny, E. Santer, E. Pirich, H. Schennach, and D. Fuchs Delta9-tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro J Neuroimmunol 207 2009 75 82
35. J. Gostner, S. Schroecksnadel, K. Becker, M. Jenny, H. Schennach, and F. Ueberall Antimalarial drug chloroquine counteracts activation of indoleamine (2,3)-dioxygenase activity in human PBMC FEBS Open Bio 2 2012 241 245
36. S. Schroecksnadel, R. Sucher, K. Kurz, D. Fuchs, and G. Brandacher Influence of immunosuppressive agents on tryptophan degradation and neopterin production in human peripheral blood mononuclear cells Transpl Immunol 25 2011 119 123
37. P. Saha, J. Humphries, B. Modarai, K. Mattock, M. Waltham, and C.E. Evans Leukocytes and the natural history of deep vein thrombosis: current concepts and future directions Arterioscler Thromb Vasc Biol 31 2011 506 512
38. Z.M. Ruggeri Platelets in atherothrombosis Nat Med 8 2002 1227 1234
39. S.P. Gieseg, Z. Amit, Y.T. Yang, A. Shchepetkina, and H. Katouah Oxidant production, oxLDL uptake, and CD36 levels in human monocyte-derived macrophages are down-regulated by the macrophage-generated antioxidant 7,8-dihydroneopterin Antioxid Redox Signal 13 2010 1525 1534
40. M. Schumacher, B. Eber, F. Tatzber, P. Kaufmann, H. Esterbauer, and W. Klein Neopterin levels in patients with coronary artery disease Atherosclerosis 94 1992 87 88
41. M. Pertovaara, A. Raitala, M. Juonala, T. Lehtimäki, H. Huhtala, and S.S. Oja Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study Clin Exp Immunol 148 2007 106 111
42. P. Niinisalo, A. Raitala, M. Pertovaara, S.S. Oja, T. Lehtimäki, and M. Kähönen Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: the Health 2000 study Scand J Clin Lab Invest 68 2008 767 770